BradburyMW. The structure and function of the blood-brain barrier. Fedn Proc1984;43:186.
2.
BroadwellRD. Transcytosis of molecules through the blood-brain barrier: A cell biological perspective and critical appraisal. Acta Neuropath (Berl)1989;79:117.
3.
SedgwickJHughesCCWMaleDKMacPheeIAMTer MeulenV. Antigen-specific damage to brain vascular endothelial cells mediated by encephalitogenic and non-encephalitogenic CD4+ T cell lines in vitro. J Immunol1990;145:2474.
4.
MaleDKPryceGHughesCCWLantosPL. Lymphocyte migration into brain modelled in vitro: Control by lymphocyte activation cytokines and antigen. Cell Immunol1990;127:1.
5.
CrossAHCannellaBBrosnanCFRaineCS. Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localisation of 14C-labelled cells during acute, chronic and relapsing experimental allergic encephalomyelitis. Lab Invest1990;63:162.
6.
SchwartzRH. Immune responses (Ir) genes of the murine major histocompatibility complex. Adv Immunol1986; 38:31.
7.
WraithDCMcDevittHOSteinmanLAcha-OrbeaH. T cell recognition as the target for immune intervention in autoimmune disease. Cell1989;57:709.
8.
WraithDCSmilekDEMitchellDJSteinmanLMcDevittHO. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell1989;59:247–55.
9.
UrbanJLHorvathSJHoadL. Autoimmune T cells: Immune recognition of normal and variant epitopes and peptide-based therapy. Cell1989;59: 257–71.
10.
LamontAGSetteAFujinamiRColonSMMilesCGreyHM. Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for I-As molecules. J Immunol1990,145:1687.
11.
QuarlesRHIlyasAAWillisonHJ. Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system. Chem Phys Lipids1986; 42:235–48.
LatovN. Antibodies to glycoconjugates in neurological disease. Clin Aspects Autoimmun1990;4:18–29.
14.
IlyasAAWillisonHJDalakasMCWhittakerJNQuarlesRH. Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy. J Neurochem1988;51:851–8.
15.
BabaHDauneGCIlyasAA. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy. J Neuroimmunol1989;25:143–50.
16.
LatovNHaysAPDonofrioPD. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1B and to lacto-N-tetraose associated with human motor neuron disease. Neurology1988;38:763–8.
17.
PestronkACornblathDRIlyasAA. A treatable multifocal neuropathy with antibodies to GM1 ganglioside. Ann Neurol1988;24:73–8.
18.
PestronkAAdamsRNClawsonL. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology1988;38:1457–61.
19.
GregsonNAJonesDWillisonHJ. Antibodies against GM1 and other ganglioside in patients with motor neuron syndromes. In: RoseF Clifford, ed. New evidence in MND/ALS research. London: Smith-Gordon & Co. Ltd, 1991.
20.
MarcusDMLatovNHsiBPGillardBK. Measurement and significance of antibodies against GM1 ganglioside. Report of a Workshop, 18 April 1989, Chicago, IL, USA. J Neuroimmunol1989;25:255–9.
21.
IlyasAAWillisonHJQuarlesRH. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol1988;23:440–7.
22.
KoskiCLChouDKHJungalwalaFB. Anti-peripheral nerve myelin antibodies in GBS bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen. J Clin Invest1989;84:280–7.
23.
IlyasAAMithenFAChenZ-WCookSD. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome. J Neurol Sci1991;102:67–75.
24.
PrineasJW. The neuropathology of multiple sclerosis. In: Handbook of clinical neurology. Amsterdam: Elsevier, 1985:213–57.
25.
CompstonAScoldingNWrenDNobleM. The pathogenesis of demyelinating disease: Insights from cell biology. Trends Neurosci1991;14:175–182.
26.
ScoldingNJMorganBPHoustonALiningtonCCampbellAKCompstonDAS. Vesicular removal by oligodendrocytes of membrane attach complexes formed by complement. Nature1989;339:620–2.
27.
ScoldingNJCompstonDAS. Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies. Immunology1990;72:127–32.
28.
GayDEsiriM. Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytochemical study. Brain1991;114:557–72.
29.
CraggsRIKingRHMThomasPK. The effect of suppression of macrophage activity on the development of experimental allergic neuritis. Acta Neuropathol (Berl)1988;23:326–31.
30.
SobueGYamatoSHirayamaM. The role of macrophages in demyelination in experimental allergic neuritis. J Neurol Sci1982;56:75–87.
31.
TrotterJSmithME. The role of phospholipases from inflammatory macrophages in demyelination. Neurochem Res1986;11:349–61.
32.
HartungH-PSchaferBHeiningerKToykaKV. Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase. Ann Neurol1988;23:453–60.
33.
HartungH-PSchaferBHeiningerKStollGToykaKV. The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Brain1988;111:1039–59.
34.
StollGSchmidtBJanderSToykaKVHartungHP. Presence of the terminal complement complex (C5b-9) precedes myelin degradation in acute demyelination in the peripheral nervous system of the rat. Ann Neurol1991;30:147–55.
35.
HartungH-PSchäferBVan der MeidePHFierzWHeiningerKToykaKV. The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol1990; 27:247–57.
